I think the Scar prevention should be considered as another Indication of SNT 5505, not another drug.
SNT 6302 shouldn't be there in first place.
That's not big deal but Gary should at least explain to the shareholders why this is being pushed further and further into Q4.
- Forums
- ASX - By Stock
- SNT
- Ann: Quarterly Activities Report
SNT
syntara limited
Add to My Watchlist
3.92%
!
5.3¢

Ann: Quarterly Activities Report, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $86.12M |
Open | High | Low | Value | Volume |
5.1¢ | 5.3¢ | 5.0¢ | $178.5K | 3.485M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26087 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 6328 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26087 | 0.051 |
6 | 374990 | 0.050 |
4 | 335097 | 0.049 |
2 | 221000 | 0.048 |
1 | 75000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 6328 | 2 |
0.054 | 350000 | 1 |
0.055 | 150000 | 1 |
0.057 | 483082 | 1 |
0.058 | 101600 | 2 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |